HLAVNÍ TÉMA Specifika diagnostiky a léčby multimorbidních pacientů 180 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék. 2023;69(3):173-180 / www.casopisvnitrnilekarstvi.cz of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the spe‑ cial contribution of the European Heart Rhythm Association (EHRA) of the ESC, Eur He‑ art J. 2021 Feb 1;42(5):373-498. 3. Farmer C, et al. Clinical assessment and management of multimorbidity: summary of NICE guidance. BMJ. 2016 Sep 21;354:i4843. 4. Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross‑sectional study. Lancet,380,37-43. 5. Valderas JM, Starfield B, Sibbald B et al. Defining comorbidity: implications for under‑ standing health and health services. Ann Fam Med. 2009;7(4):357-363. 6. de Groot V, Beckerman H, Lankhorst GJ, et al. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003;56(3):221-229. 7. Huntley AL, Johnson R, Purdy S, et al. Measures of multimorbidity and morbidity bur‑ den for use in primary care and community settings: a systematic review and guide. Ann Fam Med. Mar‑Apr 2012;10(2):134-41. 8. Newschaffer CJ, Bush TL, Penberthy LT. Comorbidity measurement in elderly fema‑ le breast cancer patients with administrative and medical records data, J Clin Epidemiol. 1997,50:725-733. 9. Charlson ME, Charlson RE, Peterson JC, et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234-1240. 10. Salvi F, Miller MD, Grilli A, et al. A manual of guidelines to score the modified cumula‑ tive illness rating scale and its validation in acute hospitalized elderly patients.J Am Geri‑ atr Soc. 2008 Oct;56(10):1926-31. 11. Donnan PT, Dorward DW, Mutch B, et al. Development and validation of a model for predicting emergency admissions over the next year (PEONY): a UK historical cohort stu‑ dy. Archives of Internal Medicine. 2008; 168(13):1416-1422. 12. Hippisley‑Cox J, Coupland C. Predicting risk of emergency admission to hospital using primary care data: Derivation and validation of QAdmissions score. BMJ Open. 2013 Aug 19;3(8):e003482. 13. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated phar‑ macy data. J Clin Epidemiol. 1992;45(2):197-203. 14. Bernabeu‑Wittel M, Para O, Voicehovska J, et al; EFIM Multimorbidity Working Group. Competences of internal medicine specialists for the management of patients with mul‑ timorbidity. EFIM multimorbidity working group position paper. Eur J Intern Med. 2023 Mar;109:97-106. 15. Lyness JM, Niculescu A, Tu X, et al. The relationship of medical comorbidity and depre‑ ssion in older, primary care patients.Psychosomatics. 2006;47(5):435-9. 16. European guide for management of frailty at individual level including recommen‑ dations and roadmap. https://www.advantageja.eu/images/D6.2_EuropeanGuide_Ma‑ nagement.pdf 17. Butchart A, Kerr EA, Heisler M, et al. Experience and management of chronic pain among patients with other complex chronic conditions. Clin J Pain. 2009 May;25(4):293-8. 18. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for ol‑ der patients with multiple comorbid diseases. JAMA. 2005;294:716-24. 19. Guthrie B, Payne K, Alderson P, et al. Adapting clinical guidelines to take account of multimorbidity. BMJ. 2012;345:e6341. 20. Leśniak W, Morbidoni L, Dicker D, et al. EFIM Clinical practice guidelines adaptation for internists – an EFIM methodology.Eur J Intern Med. 2020;77:1-5. 21. Kostev K, Jacob L. Multimorbidity and polypharmacy among elderly people followed in general practices in Germany. Eur J Intern Med. 2018 Sep;55:66-68. 22. Masnoon N, Shakib S, Kalisch‑Ellett L, et al. What is polypharmacy? A systematic re‑ view of definitions. BMC Geriatr. 2017 Oct 10;17(1):230. 23. Chang TI, Park H, Kim DW, et al. Polypharmacy, hospitalization, and mortality risk: a na‑ tionwide cohort study. Sci Rep. 2020 Nov 3;10(1):18964. 24. Burt J, Elmore N, Campbell SM, et al. Developing a measure of polypharmacy appro‑ priateness in primary care: systematic review and expert consensus study. BMC Med. 2018 Jun 13;16(1):91. 25. The 2019 American Geriatrics Society (AGS) Beers Criteria® Update Expert Panel (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019 Apr;67(4):674-694. 26. Naugler CT, Brymer C, Stolee P, et al. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol. 2000 Summer;7(2):103-7. 27. Barry PJ, Gallagher P, Ryan C, et al. START (screening tool to alert doctors to the right treatment) –an evidence‑based screening tool to detect prescribing omissions in elderly patients. Age and Ageing. 36(6):632-638. 28. O’Mahony D. STOPP/START criteria for potentially inappropriate medications/poten‑ tial prescribing omissions in older people: origin and progress. Expert Rev Clin Pharma‑ col. 2020 Jan;13(1):15-22. 29. Pazan F, Weiss C, Wehling M. FORTA. The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults. Drugs Aging. 2022 Mar;39(3):245-247. 30. Scott IA, Le Couteur DG. Physicians need to take the lead in deprescribing. Intern Med J. 2015 Mar;45(3):352-6. PŘEDNÁŠKY Úvod – MUDr. Tomáš Nežádal, Ph.D. Migréna u praktického lékaře – MUDr. Irena Novotná Bolest dolní končetiny, (pseudo)radikulární syndrom – MUDr. Luboš Dušek Bolest zad – klinický algoritmus, možnosti intervenční léčby – MUDr. Michal Adam Bolest hlavy – jde opravdu o migrénu? – MUDr. Irena Novotná ODBORNÝ GARANT MUDr. Tomáš Nežádal, Ph.D. Ústřední vojenská nemocnice – Vojenská fakultní nemocnice Praha MEDIÁLNÍ PARTNER POČET KREDITŮ 2 Registrace ZDARMA TERMÍN duben 2023 až březen 2024 dostupný na online.solen.cz Nové trendy v léčbě migrény a jiné bolesti ON LINE KURZ Vnitřní lékařství Medicína pro praxi
RkJQdWJsaXNoZXIy NDA4Mjc=